Jin Yang Pharmaceutical Chairman Choi Yun-hwan Donates 200,000 Shares, Stake Drops from 2.34% to 0.92% with Limited Impact on Shareholder Value

Choi Yun-hwan, non-registered executive and chairman of Jin Yang Pharmaceutical, donated 200,000 common shares to individuals on May 29, 2026, reducing his stake from 2.34% to 0.92%, a decrease of 1.42 percentage points.
The donations were made to two recipients, Hwang Soon-il and Ha Jae-sung, each receiving 100,000 shares. This is a personal share transfer unrelated to corporate capital changes or fundraising.
Since no corporate capital expansion or convertible bond issuance is involved, the risk of dilution or shareholder value impairment is low. The event is considered neutral from a governance perspective.
[AI Summary]The chairman's personal donation does not affect the company's financial structure, and there are no plans for additional fundraising or dividend policy changes, limiting the practical risk to investors. However, the reduction in major shareholder stake could be interpreted as a decrease in potential overhang risk.